Multiple Sclerosis and Related Disorders

Papers
(The H4-Index of Multiple Sclerosis and Related Disorders is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Test-retest reliability of the Swedish version of the Modified Fatigue Impact Scale in people with mild to moderate multiple sclerosis70
Preliminary race-ethnicity-based analyses of fall risk among people with multiple sclerosis67
Real-World Evidence with Five-Year Data (2017-2022) on the Use of Cladribine Tablets in Patients with Multiple Sclerosis in England: an Updated Analysis from the CLARENCE Study61
EDSS and Infratentorial White Matter Lesion Volume are Considered Predictors of Fatigue Severity in RRMS57
Influence of Cigarette, and Waterpipe Smoking, Alcohol, and Drug Consumption on the Occurrence of Late-Onset Multiple Sclerosis55
57. Cognitive Decline and Motor Handicap in Multiple Sclerosis Patients54
143. Navigating the Maze of Multiple Sclerosis Disease Modifying Therapies: Insights from Iran's National MS Registry51
Impact of insurance status on MRI phenotypes in MS50
157. Remibrutinib Exposure in Cerebrospinal Fluid: Insights from a Study in Healthy Subjects44
125. Investigating Psychoses in Pediatric-Onset Multiple Sclerosis: A Systematic Review of Case Reports43
Lipid measures are associated with cognitive functioning in multiple sclerosis patients41
Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran41
Evaluation of adherence to treatment in patients with multiple sclerosis from Latin America39
Leber Hereditary Optic Neuropathy Presenting as Bilateral Visual Loss and White Matter Disease39
“It's on the tip of my tongue!” exploring confrontation naming difficulties in patients with multiple sclerosis39
Peripheral nerve vulnerability as risk factor for multiple sclerosis: Possible insights from Neurofibromatosis type 2 (NF2)37
Involvement Peripheral Nerve System in Multiple Sclerosis36
Index of cardiac-electrophysiological balance in relapsing–remitting multiple sclerosis patients treated with fingolimod35
The Use of Ocrelizumab in Pediatric Multiple Sclerosis Patients in the United Arab Emirates: A Retrospective Study35
Characteristics of recurrence risk perception and coping strategies in patients with neuromyelitis optica spectrum disorder: A qualitative study35
Characterizing causal relationships of visceral fat and body shape on multiple sclerosis risk34
Sexual Dysfunctions and Self-Esteem in Multiple Sclerosis: A Tunisian Study34
Functional electrical stimulation combined with voluntary cycling accentuates VO2 response in people with severe multiple sclerosis: A pilot study34
Incidence of multiple sclerosis relapses and pseudo-relapses following COVID-19 vaccination33
Markedly elevated cerebrospinal fluid white blood cell count in multiple sclerosis: How high is too high?33
Symptoms of PTSD and depression in newly diagnosed people with multiple sclerosis during the outbreak Oct.7th war on Gaza: A case-control study from Jordan33
Can neurofilament lightchain as endpoint in Phase 2 derisk clinical disability worsening in Phase 3 in multiple sclerosis?33
A critical evaluation of machine learning approaches for screening depression and anxiety in early multiple sclerosis30
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina30
Coexistence of epilepsy or seizure and multiple sclerosis; a single center experience29
Effects of constraint induced movement therapy in patients with multiple sclerosis: A systematic review29
The effects of bupropion on sexual dysfunction in female patients with multiple sclerosis: A double-blind randomized clinical trial29
0.074405193328857